Maternal Health

CA-IeDEA investigators are exploring the intersections of HIV and maternal health. This work includes:

  • Examining outcomes among HIV-exposed uninfected (HEU) children in the option B/B+ era. Linked mother-infant data from sites offering prevention of mother-to-child transmission (PMTCT) services are being used to determine the effect of exposure to HIV and ART on pregnancy outcomes, including the effect of in-utero exposure to HIV and ART on neonatal and infant death.
  • Using community growth monitoring data to examine the long-term survival and growth of HEU children.
  • Studying long-term outcomes among women who initiated lifelong ART during pregnancy. This research is evaluating the effectiveness of Data Driven Continuous Quality Improvement interventions in improving long-term retention in care and virological suppression in women who start lifelong ART during pregnancy, with a focus on identifying health system factors associated with retention in care and sustained virological suppression.
  • Examining pre-ART attrition (i.e., loss to care) among pregnant and breastfeeding women, with the aim of identifying drivers of high attrition rates among pregnant and postpartum women.

CA-IeDEA’s maternal health research is led by Dr. Marcel Yotebieng of Albert Einstein College of Medicine.